SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $42,450,000 | -27.0% | 369,325 | -0.8% | 1.84% | -26.0% |
| Q3 2014 | $58,164,000 | +34.9% | 372,275 | +6.5% | 2.48% | +63.9% |
| Q2 2014 | $43,128,000 | +6.2% | 349,640 | -10.8% | 1.52% | +4.2% |
| Q1 2014 | $40,620,000 | -0.5% | 392,050 | -13.7% | 1.46% | +3.3% |
| Q4 2013 | $40,842,000 | +19.0% | 454,100 | -11.5% | 1.41% | +21.4% |
| Q3 2013 | $34,323,000 | -17.2% | 513,200 | -18.1% | 1.16% | -30.8% |
| Q2 2013 | $41,463,000 | – | 626,800 | – | 1.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |